Objective. To study whether patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) differ from healthy individuals in their immune responses to acute psychological stress.
The pathogenesis of chronic inflammatory autoimmune diseases such as rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) is still unknown. Both inflammatory diseases are characterized by the presence of autoantibodies which play a major role in these entities. In healthy individuals, antibody production is regulated by a well-controlled network of immunocompetent cells predominantly co-ordinated by cytokines.
Therefore, several studies have investigated the cytokine profile of SLE and RA patients in vivo and in vitro. Despite the inconsistent findings of either increased or decreased levels of interleukin (IL)-2, IL-4, IL-6, IL-10 or interferon (IFN) c in RA and SLE patients in comparison with healthy controls, these studies confirm that SLE and RA patients display an altered cytokine profile w1-5x.
Recent experimental data demonstrate that lymphocyte subpopulations and cytokine production are also controlled by factors of the neuroendocrine system w6, 7x. These data are paralleled by clinical observations suggesting an association between stress, life events, and disease activity in autoimmune patients w8-10x. In healthy individuals, acute psychological stress induces a transient increase in peripheral blood lymphocytes, with the most pronounced alterations in natural killer (NK) cell numbers w11-13x. Stress-induced changes are mediated mainly via sympathetic activation of b-adrenoceptors on lymphocytes w14x.
Preliminary experimental findings support the hypothesis that in autoimmune patients the response of the sympathetic nervous system to stress differs from healthy controls w15-18x. Observations in SLE and RA patients demonstrated an altered number of b-adrenoceptors on peripheral blood mononuclear cells (PBMC) w19, 20x. Experimental observations in animals and humans suggest that both a-and b-adrenergic mechanisms modulate cellular immune functions and disease activity in chronic inflammation w21x. Treatment with a non-selective b-adrenergic receptor blocker in rats with experimentally induced arthritis significantly reduced disease symptoms w15x. However, whether and to what extent the neuroendocrine-immune comunication is disturbed in autoimmune patients such as RA and SLE patients is unknown at present. Thus, in the present study we investigated whether SLE and RA patients differ from healthy individuals in the circulation of lymphocyte subpopulations, NK cell activity, and cytokine pattern before, immediately after, and 1 h after stress exposure, using public speech as a stress model w22, 23x.
Patients and methods
Patients and subjects Nine female RA patients (mean age 44.2 yr, range 31-60 yr), seven female patients with SLE (mean age 39.0 yr, range 20-61 yr), and 15 age-matched healthy female volunteers (mean age 39.0 yr, range 24-58 yr) participated in the study after informed consent. The SLE patients with active disease according to SLEDAI w24x were recruited from the out-patient clinic at Hannover Medical School and had been diagnosed according to the criteria of the American Rheumatism Association (ARA) w25, 26x. An assessment of disease activity in the RA patients during the last 14 days, according to the RADAR score w27, 28x, revealed 14.63 " 3.78 for painutenderness (scale: 0-60) and 1.87 " 0.3 for level of function (scale: 0-4). The study was approved by the ethics committee of Hannover Medical School for human experimentation. Subjects with significant cardiovascular diseases, concurrent infections, or any history of other autoimmune disorders were excluded. All patients in this study were free of immunosuppressive medication. One patient was medicated with hydroxychloroquine (250 mguday) and five patients took low doses of methotrexate (10-20 mguweek). There were no significant immunological differences comparing treated with untreated patients. The patients displayed no exacerbation of their disease activity at least 4 weeks prior to the onset of the experiment. In addition, for at least 4 weeks prior to the experiment, all subjects were free of medications such as anti-depressants, adrenoceptor antagonists, and benzodiazepines, which were suspected of altering immunological or affective responsiveness. Individuals with drug or alcohol abuse were excluded from this study.
Experimental design and procedure
The subjects were informed that the purpose of the study was to measure the effect of emotional state on immune responsiveness during their performance of a public talk. The experimental sessions were conducted between 8.30 and 11.30 a.m. The subjects were requested to avoid caffeine on the morning of the study. Upon arrival in the laboratory, the volunteers were seated in a chair facing a movable wall, and remained so throughout the entire experiment. After giving informed consent and resting for 10 min, an indwelling cannula was inserted into a prominent forearm vein. Thirty minutes after inserting the cannula the first blood sample (baseline) was drawn.
Acute psychological stress was induced by public talking. Three minutes after starting, the talk was interrupted and the second blood sample (stress) was drawn. The subjects were then asked to sit quietly and relax for the remaining time until the third blood sample was drawn 60 min after the stress exposure (follow-up).
White blood cells (WBC)
Blood was drawn using potassium-ethylene diamine tetraacetic acid (EDTA) Monovetten 2 (Sarstedt, Nü mbrecht, Germany) or in heparinized syringes for immunological analyses. WBC were counted automatically with STKS (Coulter Electronics Inc., Hialeah, USA).
Catecholamine concentrations
All blood samples were centrifuged at 48C and the plasma stored at 2 808C until assayed. All samples of one subject were analysed in the same assay. Catecholamine plasma levels were analysed using modified high-performance liquid chromatography (HPLC).
Monoclonal antibodies (mab)
Labelled mab directed against the respective human leucocyte antigens CD2 fluorescein isothiocyanate (FITC), CD4 FITC, CD8 phycoerythrin (PE), CD16 FITC (DAKO, Hamburg, Germany), CD3 FITC (Immunotech, Hamburg, Germany), CD3 PE, CD20 FITC, and CD56 PE (Becton Dickinson, Heidelberg, Germany) were used. The following mab for the detection of intracellular cytokines were purchased from Pharmingen (Hamburg, Germany): a-IFNc, FITC, a-IL-2 PE, a-IL-4 PE, a-IL-6 PE, a-IL-10 PE. For all cytofluorometric experiments, appropriate isotype control antibodies (PEuFITC) were utilized.
Phenotypic analyses
Phenotypic analyses were performed using two-colour immunofluorescences in Ficoll-Hypaque-separated cell samples utilizing directly labelled mab as described previously w29x. Briefly, 1-3 3 10 5 cellsuwell were incubated with murine mab against the appropriate antigen at an optimal dilution for 30 min at 48C. Non-specific binding was eliminated by mixing the samples with a 1 : 5 solution of a commercial human immunoglobulin G (IgG; Intraglobin, Biotest, Frankfurt, Germany). The samples were washed three times in phosphate-buffered salineubovine serum albumin (PBSuBSA), and at least 10 4 cells per lymphocyte or monocyte gate were analysed using a FACScan (Becton Dickinson). The gates were set according to the forward scatter (FSC) and sideward scatter (SSC) properties of the cells.
Cell stimulation
After Ficoll separation, 2 3 10 6 PBMC were resuspended in 1 ml of culture medium wRPMI 1640 supplemented with 10% fetal calf serum (FCS) and 1% penicillinustreptomycin solutionx. The cells were then stimulated by the addition of 10 ng phorbol 12-myristate 13-acetate (PMA) and 1 mM ionomycin. One minute later the transport inhibitor monensin (2.5 mM) was added to prevent the secretion of the induced cytokines into the supernatant. After 4 h of culture at 378C and 5% CO 2 the cells were harvested for further analyses.
Whole blood culture
Heparinized fresh blood from all three time points was diluted 1 : 10 with RPMI. These cell suspensions were cultured for either 24 h in the presence of phytohaemagglutinin (PHA) or for 36 h with lipopolysaccharide (LPS). After appropriate incubation times, cell-free supernatants of these cultures were carefully harvested and kept frozen in aliquots at 2 208C until analysis.
Staining of intracellular cytokines
After stimulation, the cells were washed with PBSuBSA and fixed for 10 min at room temperature in PBS containing 4% paraformaldehyde. The cells were then washed and resuspended in saponin buffer (PBS supplemented with 5 mM HEPES and 0.1% saponin). Subsequently, aliquots were stained simultaneously with mab against intracellular cytokines and surface antigens. Non-specific binding of the mab via Fc receptors was discriminated by adding human IgG solution. After 30 min incubation at 48C the cells were washed once with saponin buffer and twice with PBSuBSA. After resuspension the cells were ready for FACS analysis.
Determination of soluble cytokines
Cytokines from supernatants of whole blood cultures were determined using commercial enzyme-linked immunosorbent assay (ELISA) kits for IFNc, IL-6 (Bender, Vienna, Austria), IL-2, IL-4, and IL-10 (Biosource, Ratingen, Germany) according to the manufacturers' recommendations.
NK assay Standard 4 h
51 Cr release cytotoxicity assays were performed using cryopreserved PBMC. Frozen samples were rapidly thawed with three washes in RPMI 1640 and finally resuspended in medium supplemented with 10% FCS. One hour later the cells were counted and added in triplicate at four effector to target (EuT) ratios (60 : 1, 30 : 1, 15 : 1, and 7.5 : 1) in V-bottom microtitre plates with 5 3 10 3 51 Cr-labelled K562 target cells per well, as previously described in detail w30x. The medium for the cytotoxicity assays was RPMI 1640 supplemented with 5% FCS and 1% penicillinustreptomycin. The assays were incubated for 4 h. Specific cytotoxicity was measured by determining released 51 Cr. Background values were determined by incubating target cells without effector cells. Maximal values were obtained by lysing target cells with Triton X-100 (Sigma, St Louis, MO, USA). Specific lysis was calculated by: w(experimental release 2 spontaneous release)u (maximum release 2 spontaneous release)x 3 100
For a more precise analysis of cytotoxic capacity, lytic units were calculated according to the method of Bryant et al. w31x. Using this mathematical transformation the sigmoid dose-response relationship between the number of employed effectors and measured cytotoxicity can be linearized. Lytic units calculated in this way allow a comparison of cytotoxicity assays performed at different points of time.
Statistical analyses
Statistical analyses of the data were performed using ANOVAs with repeated measures. If not otherwise stated, the group 3 time interaction effect is given for the differences between SLE and healthy controls or RA and healthy controls.
Results

Catecholamine concentrations
The stress of public speaking significantly increased plasma concentrations of adrenaline and noradrenaline in patient groups and healthy individuals with no significant differences between groups (data not shown) w32x.
WBC kinetics
Public speaking increased WBC numbers in all groups with significantly less pronounced changes in SLE patients compared with controls (P < 0.005). SLE patients displayed leucopenia reflected by significantly lower lymphocyte numbers compared with healthy controls (P < 0.001, group effect). In addition, stressinduced increases in lymphocyte numbers were observed in all three groups (Table 1) .
Lymphocyte subsets
Due to lower absolute numbers of lymphocytes, SLE patients had reduced lymphocyte subset counts at all three time points (Fig. 1a-c) . T lymphocyte (CD3 numbers increased after stress exposure in all groups (healthy controls P < 0.01, SLE and RA P < 0.05; Fig. 1a ). The same was true for CD8 + cells in all groups (P < 0.05, Fig. 1c) . However, stress-induced changes in CD4 + cell numbers were only observed in RA patients (P < 0.05), but not in SLE patients or healthy controls (Fig. 1b) . The most pronounced stress-induced effect was observed in NK (CD16 + uCD56 + ) cell numbers of patients and healthy controls (Fig. 2a) . However, these stress-induced changes in NK cell numbers were significantly blunted in SLE patients (P < 0.01).
In healthy controls, the kinetics of NK cell numbers were paralleled by the cytotoxic capacity against K562 target cells. In contrast, SLE and RA patients did not exhibit significantly enhanced cytotoxicity after stress, despite an increase in NK cell numbers (Fig. 2b) .
Cytokine production
To ascertain whether leucocytes from RA and SLE patients differed functionally from those of healthy controls, the cytokine-producing capabilities of WBC were analysed. Cytokine levels were determined from PHA (IFNc, IL-2, IL-4, IL-6, IL-10) or LPS (IL-6, IL-10) culture supernatants by ELISA. IFNc levels in healthy controls were 3-fold higher at baseline compared with both patient groups, increased during stress exposure, and returned to baseline values 1 h later (P < 0.05). In contrast, in SLE and RA patients, IFNc levels were not affected by public speech (Fig. 3a) .
Analyses of IL-2 levels revealed no differences between time points or patient groups and healthy controls ( Table 2) . PHA-driven supernatants from SLE and RA patients contained approximately 60% of the IL-6 (n.s.) and 25% of the IL-10 (P < 0.05) concentration that was measured from healthy individuals (Fig. 3b) . The production of both cytokines was not affected by stress exposure.
Supernatants from LPS cultures from SLE and RA patients contained less IL-6 than cultures from healthy controls, without reaching statistical significance. These IL-6 levels did not change between the three time points in all three groups (Table 3) . IL-10 levels from LPSdriven supernatants did not differ between patients and controls and were not affected by stress exposure.
Intracellular cytokines
To determine cytokine production on the single-cell level, intracellular cytokines were determined by FACS. To induce maximal cytokine synthesis, the cells were first stimulated with PMA and ionomycin. Under these conditions, patients and healthy volunteers displayed comparable numbers of IFNc + cells at baseline. However, IFNc + cell numbers subsequently increased by about 50% after stress exposure and returned to baseline values 1 h later (Fig. 4a) . In contrast, SLE patients exhibited absolutely lower, and RA patients higher, numbers of IL-2-producing cells compared with controls, without reaching statistical significance
FIG. 1. Composition of lymphocyte subsets significantly changed after stress induction. (a) CD3
+ (healthy controls I, P < 0.01; SLE m and RA m, P < 0.05) and (c) CD8 + (P < 0.05) lymphocytes increased after stress exposure in all groups. (b) Stress-induced changes in CD4 + cell numbers were only observed in RA patients (P < 0.05), but not in SLE patients or healthy controls.
(P < 0.06). However, in all groups, IL-2 + cell numbers remained unchanged over time (Fig. 4b) .
Analogous analyses performed for Th2 cytokines revealed that IL4 + cells were not affected by stress in RA patients and healthy controls. IL4
+ cells of SLE patients, however, increased after stress by about 100% and subsequently dropped to baseline values (P < 0.01) (Fig. 5) . In contrast, numbers of IL-6 + and IL-10 + cells did not differ between healthy controls and SLE and RA patients and remained unaffected by stress exposure (data not shown).
In addition, cell samples stained with aIL-10 antibodies were also gated on monocytes according to their properties in a FSC vs SSC display. However, IL-10 + monocyte numbers did not differ between groups and did not change during the whole experiment (data not shown).
To assess whether stress can directly induce cytokine production, freshly isolated cells were analysed without prior stimulation by PMAuionomycin or LPS. These experiments revealed no spontaneous cytokine production of non-stimulated cells at any time.
Discussion
Acute psychological stress induced by a public talk induced a sympathetic activation with significant increases in heart rate, blood pressure, and blood catecholamine concentration w22, 32x. In parallel, leucocyte and lymphocyte counts, in particular of CD16 + uCD56 + NK cell numbers, increased transiently in blood of patients and controls. This concurs with (a) IFNc levels in healthy controls (I, n = 10) were 3-fold higher at baseline compared with both patient groups, increased during stress exposure, and returned to baseline values 1 h later (P < 0.05). In contrast, in SLE (m, n = 4) and RA (m, n = 7) patients, IFNc levels were not affected by public speech. (b) Supernatants from SLE and RA patients contained approximately 25% of the IL-10 of healthy controls (P < 0.05). The production of this cytokine was not affected by stress exposure. Data are presented as mean " standard error. TABLE 2. IL-2 and IL-6 levels were analysed by ELISA (mean " standard error of the mean). Whole blood samples from the indicated time points had been stimulated for 24 h with PHA. Differences between healthy controls and RA or SLE patients in regard to IL-2 and IL-6 production failed to reach statistical significance Baseline Stress Follow-up IL-2 (pguml) RA (n = 7) 796 " 233 717 " 194 666 " 334 Controls (n = 10) 409 " 104 477 " 132 400 " 145 SLE (n = 4) 661 " 250 618 " 302 775 " 429 IL-6 (pguml) RA (n = 7) 5141 " 1728 5418 " 1206 4317 " 2135 Controls (n = 10) 7520 " 1678 6831 " 1484 4287 " 1077 SLE (n = 5) 4646 " 1525 4690 " 2519 2148 " 1000 the results of previous studies with healthy subjects employing either similar or different models of acute psychological stress w11, 14, 23, 33, 34x. SLE patients presented lower total lymphocyte counts and respective subset numbers, reflecting lymphopenia normally observed in these patients. Moreover, all stress-induced changes in lymphocyte subpopulations (CD3 + , CD4 + , CD16 + uCD56 + ) were less pronounced in SLE patients compared with controls or RA patients.
The only two studies so far involving SLE patients yielded inconsistent results for stress-induced alterations in lymphocyte subpopulations. Hinrichsen et al. w18x observed unchanged or reduced percentages of lymphocyte subpopulations despite elevated catecholamine concentrations after 2 h of neuropsychological testing in patients and healthy controls. In contrast, concurring with the present data, the same group reported a significant increase in percentages of lymphocyte subsets, in particular CD8 + cells, after an acoustic stressor in both controls and SLE patients. However, two-colour fluorescence analyses in our study revealed that the changes in CD8
+ cells in patients and controls were caused predominantly by changes in CD8 + NK cells (data not shown) w12x.
The functional capacity of NK cells to kill target cells in vivo increased significantly after stress exposure in healthy controls, but not in SLE or RA patients. In standard NK assays there is a strong correlation between target number and effector ratio which allows a comparison of the killing capacity of different individuals after calculation of lytic units. Thus, at least in RA patients, an expected marked enhancement of NK cytotoxicity in parallel to the increases in NK cells under stress was not observed. This suggests an aberrant regulation of NK activity in RA patients. Previous data support this finding w35x, where the activity of peripheral blood NK cells could be downregulated by immune complexes isolated from synovial fluid. Therefore, the exhaustion of cytolytic activity in RA and the lack of increased activity may be due to prior in vivo activation of NK cells via CD16 w36x. We propose that NK cells in patients suffering from SLE or RA are less active due to permanent activation as a consequence of the inflammatory disease. Under these conditions, additional pre-activated NK cells that are recruited under stress may not be able to + cells were not affected by stress in RA patients and healthy controls. IL4
+ cells of SLE patients, however, increased after stress by about 100% and dropped to baseline values afterwards (P < 0.01). Data are presented as mean " standard error.
enhance tumour killing efficiently. Furthermore, in healthy individuals and patients, NK cells may be recruited from different immune compartments where the functional capacity of NK cells is altered w14x.
It has been shown that adrenaline is one of the main factors responsible for lymphocyte trafficking under acute psychological stress or physical exercise w12, 14, 37x. Other immune mediators that are potentially under the influence of acute stress are cytokines. Several studies which have already focused on this issue using different approaches have yielded inconsistent results.
In SLE patients and healthy controls we observed comparable levels of IL-2, but lower levels of IFNc in SLE patients. Our experimental paradigm employed whole blood cultures without cell adjustment prior to the assays. Thus, it would be expected that all cytokine concentrations from SLE patients would be approximately half those of healthy controls, as SLE patients displayed only about half as many cells in peripheral blood compared with controls. Taking this into account, SLE patients displayed relatively elevated IL-2 after PHA stimulation. However, IFNc was below control levels. In contrast to healthy volunteers, there were no changes in these cytokine concentrations throughout the whole experiment. RA patients exhibited increased IL-2 but diminished IFNc levels compared with controls.
In general, measuring cytokines from plasma and serum samples or culture supernatants does not reflect real in vivo conditions. Cytokines do not effectively regulate immune functions systematically, but rather in low concentration near the effector site. In addition, in vitro analyses of cytokine levels in supernatants from activated cells are tempered by consuming cells within the bulk cultures. Furthermore, these culture conditions enable activated cells to proliferate. All these factors can affect the actual cytokine levels measured in the supernatant.
Thus, for a more accurate reflection of the in vivo situation we analysed intracellular cytokine production in mononuclear cells which were freshly isolated from peripheral blood. This method enables the direct identification of cytokines produced in single cells. The blockade of transport mechanisms in the cells inhibits the secretion of mediators, preventing any loss by cytokine consumption. In addition, due to the short culture time (4 h) of the assay, cell proliferation as an error source can be excluded.
Using this technique, analyses revealed that the number of IL-4 + cells in SLE patients increased transiently under stress. IL-4 is known to drive powerful clonal proliferation and expansion of activated B cells which may lead to enhanced immunoglobulin secretion. Thus, it may be possible that stress exposure can induce exacerbation of SLE by activating autoreactive B-cell clones via an increase in IL-4-providing cells. In addition, the lack of immunosuppressive IL-10, as observed in culture supernatants from SLE and RA patients, may further contribute to increased disease activity. Analysing intracellular Th1 cytokines, we detected no significant differences in IL-2 + and IFNc + cells between healthy controls and patients.
With regard to Th2 cytokine-producing cells, there were neither significant differences between SLE or RA patients and healthy controls for IL-6 + and IL-10 + cell numbers, nor were these cell numbers affected by stress exposure. In addition, public speaking did not alter IL-4 + cell numbers in healthy controls and RA patients. The lack of spontaneous cytokine production by freshly isolated cells from different time points without prior in vitro stimulation indicates that stress-released mediators do not directly induce the production of cytokines.
In summary, we observed differences in cytokine patterns between healthy controls and both SLE and RA patients. The recruitment of IL-4 + cells in SLE patients and the relatively decreased IL-10 production in SLE and RA patients in an acute stress situation may cause proliferation and expansion of autoreactive B-cell clones, subsequently increasing autoantibody levels.
In accordance with previous studies in our laboratory, it is likely that changes in the different cell types observed during stress are predominantly due to leucocyte trafficking and the cells may be mainly recruited via b-adrenergic mechanisms w12, 14x. Whether the changes in cytokine-producing cells are merely due to cell trafficking or whether lymphocytes can also be triggered directly by catecholamines needs to be shown in further in vitro studies.
